Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design.
Ontology highlight
ABSTRACT: Current treatments to prevent thrombosis, namely anticoagulants and platelets antagonists, remain complicated by the persistent risk of bleeding. Improved therapeutic strategies that diminish this risk would have a huge clinical impact. Antithrombotic agents that neutralize and inhibit polyphosphate (polyP) can be a powerful approach towards such a goal. Here, we report a design concept towards polyP inhibition, termed macromolecular polyanion inhibitors (MPI), with high binding affinity and specificity. Lead antithrombotic candidates are identified through a library screening of molecules which possess low charge density at physiological pH but which increase their charge upon binding to polyP, providing a smart way to enhance their activity and selectivity. The lead MPI candidates demons
SUBMITTER: La CC
PROVIDER: S-EPMC10133246 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA